The global market for Chinese Patent Medicine for Bones and Muscles was valued at US$ 3061 million in the year 2024 and is projected to reach a revised size of US$ 4321 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Chinese Patent Medicine for Bones and Muscles Market

Chinese patent medicine are herbal medicines in Traditional Chinese medicine, modernized into a ready-to-use form such as tablets, oral solutions or dry suspensions, as opposed to herbs that require cooking (hot water extraction). This report focus on Chinese Patent Medicine for Bones and Muscles.

As an indispensable part of Traditional Chinese medicine (TCM), Chinese patent medicines have played an important role in preventing and treating diseases in China. Since they are easy to use, easy to store, and cost-effective, Chinese patent medicines have been generally accepted and widely used in Chinese clinical practice as a vital medical resource. In recent years, as TCM has developed and it has been accepted around the world, many Chinese patent medicine companies have gained international market access and successfully registered several Chinese patent medicines as over-the-counter (OTC) or prescription drugs in regions and countries that primarily use Western medicine such as the EU, Russia, Canada, Singapore, and Vietnam. Moreover, several Chinese patent medicines have been obtained the US Food and Drug Administration (FDA) approval conducting phase II or III clinical trials in the US.

This report aims to provide a comprehensive presentation of the global market for Chinese Patent Medicine for Bones and Muscles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chinese Patent Medicine for Bones and Muscles.

The Chinese Patent Medicine for Bones and Muscles market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chinese Patent Medicine for Bones and Muscles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chinese Patent Medicine for Bones and Muscles companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chinese Patent Medicine for Bones and Muscles Market Report

Report Metric	Details
Report Name	Chinese Patent Medicine for Bones and Muscles Market
Accounted market size in year	US$ 3061 million
Forecasted market size in 2031	US$ 4321 million
CAGR	5.1%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Oral Topical Others
Segment by Application	Hospital Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zhongheng Group, Fangsheng Pharmaceutical, Yunnan Baiyao Group, Beijing TRT Group, Pien Tze Huang Pharmaceutical, BaiYunShan Pharmaceutical, China Resources Sanjiu, Yiling Pharmaceutical, Jumpcan Pharmaceutical, Tasly Group, Buchang Pharmaceutical, Sunflower Pharmaceutical, Ginwa Enterprise, KPC Pharmaceutical, Jiangsu Kanion Pharmaceutical, Xintian Pharmaceutical, Henan Lingrui Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chinese Patent Medicine for Bones and Muscles company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chinese Patent Medicine for Bones and Muscles Market growing?

Ans: The Chinese Patent Medicine for Bones and Muscles Market witnessing a CAGR of 5.1% during the forecast period 2026-2031.

What is the Chinese Patent Medicine for Bones and Muscles Market size in 2031?

Ans: The Chinese Patent Medicine for Bones and Muscles Market size in 2031 will be US$ 4321 million.

Who are the main players in the Chinese Patent Medicine for Bones and Muscles Market report?

Ans: The main players in the Chinese Patent Medicine for Bones and Muscles Market are Zhongheng Group, Fangsheng Pharmaceutical, Yunnan Baiyao Group, Beijing TRT Group, Pien Tze Huang Pharmaceutical, BaiYunShan Pharmaceutical, China Resources Sanjiu, Yiling Pharmaceutical, Jumpcan Pharmaceutical, Tasly Group, Buchang Pharmaceutical, Sunflower Pharmaceutical, Ginwa Enterprise, KPC Pharmaceutical, Jiangsu Kanion Pharmaceutical, Xintian Pharmaceutical, Henan Lingrui Pharmaceutical

What are the Application segmentation covered in the Chinese Patent Medicine for Bones and Muscles Market report?

Ans: The Applications covered in the Chinese Patent Medicine for Bones and Muscles Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Chinese Patent Medicine for Bones and Muscles Market report?

Ans: The Types covered in the Chinese Patent Medicine for Bones and Muscles Market report are Oral, Topical, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Topical

1.2.4 Others

1.3 Market by Application

1.3.1 Global Chinese Patent Medicine for Bones and Muscles Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chinese Patent Medicine for Bones and Muscles Market Perspective (2020-2031)

2.2 Global Chinese Patent Medicine for Bones and Muscles Growth Trends by Region

2.2.1 Global Chinese Patent Medicine for Bones and Muscles Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chinese Patent Medicine for Bones and Muscles Historic Market Size by Region (2020-2025)

2.2.3 Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Region (2026-2031)

2.3 Chinese Patent Medicine for Bones and Muscles Market Dynamics

2.3.1 Chinese Patent Medicine for Bones and Muscles Industry Trends

2.3.2 Chinese Patent Medicine for Bones and Muscles Market Drivers

2.3.3 Chinese Patent Medicine for Bones and Muscles Market Challenges

2.3.4 Chinese Patent Medicine for Bones and Muscles Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chinese Patent Medicine for Bones and Muscles Players by Revenue

3.1.1 Global Top Chinese Patent Medicine for Bones and Muscles Players by Revenue (2020-2025)

3.1.2 Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Players (2020-2025)

3.2 Global Chinese Patent Medicine for Bones and Muscles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chinese Patent Medicine for Bones and Muscles Revenue

3.4 Global Chinese Patent Medicine for Bones and Muscles Market Concentration Ratio

3.4.1 Global Chinese Patent Medicine for Bones and Muscles Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chinese Patent Medicine for Bones and Muscles Revenue in 2024

3.5 Global Key Players of Chinese Patent Medicine for Bones and Muscles Head office and Area Served

3.6 Global Key Players of Chinese Patent Medicine for Bones and Muscles, Product and Application

3.7 Global Key Players of Chinese Patent Medicine for Bones and Muscles, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chinese Patent Medicine for Bones and Muscles Breakdown Data by Type

4.1 Global Chinese Patent Medicine for Bones and Muscles Historic Market Size by Type (2020-2025)

4.2 Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Type (2026-2031)

5 Chinese Patent Medicine for Bones and Muscles Breakdown Data by Application

5.1 Global Chinese Patent Medicine for Bones and Muscles Historic Market Size by Application (2020-2025)

5.2 Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chinese Patent Medicine for Bones and Muscles Market Size (2020-2031)

6.2 North America Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025)

6.4 North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chinese Patent Medicine for Bones and Muscles Market Size (2020-2031)

7.2 Europe Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025)

7.4 Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size (2020-2031)

8.2 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (2020-2025)

8.4 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chinese Patent Medicine for Bones and Muscles Market Size (2020-2031)

9.2 Latin America Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025)

9.4 Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size (2020-2031)

10.2 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025)

10.4 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zhongheng Group

11.1.1 Zhongheng Group Company Details

11.1.2 Zhongheng Group Business Overview

11.1.3 Zhongheng Group Chinese Patent Medicine for Bones and Muscles Introduction

11.1.4 Zhongheng Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.1.5 Zhongheng Group Recent Development

11.2 Fangsheng Pharmaceutical

11.2.1 Fangsheng Pharmaceutical Company Details

11.2.2 Fangsheng Pharmaceutical Business Overview

11.2.3 Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.2.4 Fangsheng Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.2.5 Fangsheng Pharmaceutical Recent Development

11.3 Yunnan Baiyao Group

11.3.1 Yunnan Baiyao Group Company Details

11.3.2 Yunnan Baiyao Group Business Overview

11.3.3 Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Introduction

11.3.4 Yunnan Baiyao Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.3.5 Yunnan Baiyao Group Recent Development

11.4 Beijing TRT Group

11.4.1 Beijing TRT Group Company Details

11.4.2 Beijing TRT Group Business Overview

11.4.3 Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Introduction

11.4.4 Beijing TRT Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.4.5 Beijing TRT Group Recent Development

11.5 Pien Tze Huang Pharmaceutical

11.5.1 Pien Tze Huang Pharmaceutical Company Details

11.5.2 Pien Tze Huang Pharmaceutical Business Overview

11.5.3 Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.5.4 Pien Tze Huang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.5.5 Pien Tze Huang Pharmaceutical Recent Development

11.6 BaiYunShan Pharmaceutical

11.6.1 BaiYunShan Pharmaceutical Company Details

11.6.2 BaiYunShan Pharmaceutical Business Overview

11.6.3 BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.6.4 BaiYunShan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.6.5 BaiYunShan Pharmaceutical Recent Development

11.7 China Resources Sanjiu

11.7.1 China Resources Sanjiu Company Details

11.7.2 China Resources Sanjiu Business Overview

11.7.3 China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Introduction

11.7.4 China Resources Sanjiu Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.7.5 China Resources Sanjiu Recent Development

11.8 Yiling Pharmaceutical

11.8.1 Yiling Pharmaceutical Company Details

11.8.2 Yiling Pharmaceutical Business Overview

11.8.3 Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.8.4 Yiling Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.8.5 Yiling Pharmaceutical Recent Development

11.9 Jumpcan Pharmaceutical

11.9.1 Jumpcan Pharmaceutical Company Details

11.9.2 Jumpcan Pharmaceutical Business Overview

11.9.3 Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.9.4 Jumpcan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.9.5 Jumpcan Pharmaceutical Recent Development

11.10 Tasly Group

11.10.1 Tasly Group Company Details

11.10.2 Tasly Group Business Overview

11.10.3 Tasly Group Chinese Patent Medicine for Bones and Muscles Introduction

11.10.4 Tasly Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.10.5 Tasly Group Recent Development

11.11 Buchang Pharmaceutical

11.11.1 Buchang Pharmaceutical Company Details

11.11.2 Buchang Pharmaceutical Business Overview

11.11.3 Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.11.4 Buchang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.11.5 Buchang Pharmaceutical Recent Development

11.12 Sunflower Pharmaceutical

11.12.1 Sunflower Pharmaceutical Company Details

11.12.2 Sunflower Pharmaceutical Business Overview

11.12.3 Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.12.4 Sunflower Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.12.5 Sunflower Pharmaceutical Recent Development

11.13 Ginwa Enterprise

11.13.1 Ginwa Enterprise Company Details

11.13.2 Ginwa Enterprise Business Overview

11.13.3 Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Introduction

11.13.4 Ginwa Enterprise Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.13.5 Ginwa Enterprise Recent Development

11.14 KPC Pharmaceutical

11.14.1 KPC Pharmaceutical Company Details

11.14.2 KPC Pharmaceutical Business Overview

11.14.3 KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.14.4 KPC Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.14.5 KPC Pharmaceutical Recent Development

11.15 Jiangsu Kanion Pharmaceutical

11.15.1 Jiangsu Kanion Pharmaceutical Company Details

11.15.2 Jiangsu Kanion Pharmaceutical Business Overview

11.15.3 Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.15.4 Jiangsu Kanion Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.15.5 Jiangsu Kanion Pharmaceutical Recent Development

11.16 Xintian Pharmaceutical

11.16.1 Xintian Pharmaceutical Company Details

11.16.2 Xintian Pharmaceutical Business Overview

11.16.3 Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.16.4 Xintian Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.16.5 Xintian Pharmaceutical Recent Development

11.17 Henan Lingrui Pharmaceutical

11.17.1 Henan Lingrui Pharmaceutical Company Details

11.17.2 Henan Lingrui Pharmaceutical Business Overview

11.17.3 Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction

11.17.4 Henan Lingrui Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

11.17.5 Henan Lingrui Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Zhongheng Group

Fangsheng Pharmaceutical

Yunnan Baiyao Group

Beijing TRT Group

Pien Tze Huang Pharmaceutical

Baiyunshan Pharmaceutical

China Resources Sanjiu

Yiling Pharmaceutical

Jumpcan Pharmaceutical

Tasly Group

Buchang Pharmaceutical

Sunflower Pharmaceutical

Ginwa Enterprise

KPC Pharmaceutical

Jiangsu Kanion Pharmaceutical

Xintian Pharmaceutical

Henan Lingrui Pharmaceutical

List of Tables

Table 1. Global Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Topical

Table 4. Key Players of Others

Table 5. Global Chinese Patent Medicine for Bones and Muscles Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Chinese Patent Medicine for Bones and Muscles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Chinese Patent Medicine for Bones and Muscles Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Chinese Patent Medicine for Bones and Muscles Market Share by Region (2020-2025)

Table 9. Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Chinese Patent Medicine for Bones and Muscles Market Share by Region (2026-2031)

Table 11. Chinese Patent Medicine for Bones and Muscles Market Trends

Table 12. Chinese Patent Medicine for Bones and Muscles Market Drivers

Table 13. Chinese Patent Medicine for Bones and Muscles Market Challenges

Table 14. Chinese Patent Medicine for Bones and Muscles Market Restraints

Table 15. Global Chinese Patent Medicine for Bones and Muscles Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Chinese Patent Medicine for Bones and Muscles Market Share by Players (2020-2025)

Table 17. Global Top Chinese Patent Medicine for Bones and Muscles Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chinese Patent Medicine for Bones and Muscles as of 2024)

Table 18. Ranking of Global Top Chinese Patent Medicine for Bones and Muscles Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Chinese Patent Medicine for Bones and Muscles Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Chinese Patent Medicine for Bones and Muscles, Headquarters and Area Served

Table 21. Global Key Players of Chinese Patent Medicine for Bones and Muscles, Product and Application

Table 22. Global Key Players of Chinese Patent Medicine for Bones and Muscles, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Chinese Patent Medicine for Bones and Muscles Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Type (2020-2025)

Table 26. Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Type (2026-2031)

Table 28. Global Chinese Patent Medicine for Bones and Muscles Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Application (2020-2025)

Table 30. Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Application (2026-2031)

Table 32. North America Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (2026-2031) & (US$ Million)

Table 47. Zhongheng Group Company Details

Table 48. Zhongheng Group Business Overview

Table 49. Zhongheng Group Chinese Patent Medicine for Bones and Muscles Product

Table 50. Zhongheng Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 51. Zhongheng Group Recent Development

Table 52. Fangsheng Pharmaceutical Company Details

Table 53. Fangsheng Pharmaceutical Business Overview

Table 54. Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 55. Fangsheng Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 56. Fangsheng Pharmaceutical Recent Development

Table 57. Yunnan Baiyao Group Company Details

Table 58. Yunnan Baiyao Group Business Overview

Table 59. Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Product

Table 60. Yunnan Baiyao Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 61. Yunnan Baiyao Group Recent Development

Table 62. Beijing TRT Group Company Details

Table 63. Beijing TRT Group Business Overview

Table 64. Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Product

Table 65. Beijing TRT Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 66. Beijing TRT Group Recent Development

Table 67. Pien Tze Huang Pharmaceutical Company Details

Table 68. Pien Tze Huang Pharmaceutical Business Overview

Table 69. Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 70. Pien Tze Huang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 71. Pien Tze Huang Pharmaceutical Recent Development

Table 72. BaiYunShan Pharmaceutical Company Details

Table 73. BaiYunShan Pharmaceutical Business Overview

Table 74. BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 75. BaiYunShan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 76. BaiYunShan Pharmaceutical Recent Development

Table 77. China Resources Sanjiu Company Details

Table 78. China Resources Sanjiu Business Overview

Table 79. China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Product

Table 80. China Resources Sanjiu Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 81. China Resources Sanjiu Recent Development

Table 82. Yiling Pharmaceutical Company Details

Table 83. Yiling Pharmaceutical Business Overview

Table 84. Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 85. Yiling Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 86. Yiling Pharmaceutical Recent Development

Table 87. Jumpcan Pharmaceutical Company Details

Table 88. Jumpcan Pharmaceutical Business Overview

Table 89. Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 90. Jumpcan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 91. Jumpcan Pharmaceutical Recent Development

Table 92. Tasly Group Company Details

Table 93. Tasly Group Business Overview

Table 94. Tasly Group Chinese Patent Medicine for Bones and Muscles Product

Table 95. Tasly Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 96. Tasly Group Recent Development

Table 97. Buchang Pharmaceutical Company Details

Table 98. Buchang Pharmaceutical Business Overview

Table 99. Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 100. Buchang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 101. Buchang Pharmaceutical Recent Development

Table 102. Sunflower Pharmaceutical Company Details

Table 103. Sunflower Pharmaceutical Business Overview

Table 104. Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 105. Sunflower Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 106. Sunflower Pharmaceutical Recent Development

Table 107. Ginwa Enterprise Company Details

Table 108. Ginwa Enterprise Business Overview

Table 109. Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Product

Table 110. Ginwa Enterprise Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 111. Ginwa Enterprise Recent Development

Table 112. KPC Pharmaceutical Company Details

Table 113. KPC Pharmaceutical Business Overview

Table 114. KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 115. KPC Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 116. KPC Pharmaceutical Recent Development

Table 117. Jiangsu Kanion Pharmaceutical Company Details

Table 118. Jiangsu Kanion Pharmaceutical Business Overview

Table 119. Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 120. Jiangsu Kanion Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 121. Jiangsu Kanion Pharmaceutical Recent Development

Table 122. Xintian Pharmaceutical Company Details

Table 123. Xintian Pharmaceutical Business Overview

Table 124. Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 125. Xintian Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 126. Xintian Pharmaceutical Recent Development

Table 127. Henan Lingrui Pharmaceutical Company Details

Table 128. Henan Lingrui Pharmaceutical Business Overview

Table 129. Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product

Table 130. Henan Lingrui Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2020-2025) & (US$ Million)

Table 131. Henan Lingrui Pharmaceutical Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

Table 135. Authors List of This Report

List of Figures

Figure 1. Chinese Patent Medicine for Bones and Muscles Picture

Figure 2. Global Chinese Patent Medicine for Bones and Muscles Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chinese Patent Medicine for Bones and Muscles Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Topical Features

Figure 6. Others Features

Figure 7. Global Chinese Patent Medicine for Bones and Muscles Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Chinese Patent Medicine for Bones and Muscles Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Pharmacy Case Studies

Figure 11. Others Case Studies

Figure 12. Chinese Patent Medicine for Bones and Muscles Report Years Considered

Figure 13. Global Chinese Patent Medicine for Bones and Muscles Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Chinese Patent Medicine for Bones and Muscles Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Chinese Patent Medicine for Bones and Muscles Market Share by Region: 2024 VS 2031

Figure 16. Global Chinese Patent Medicine for Bones and Muscles Market Share by Players in 2024

Figure 17. Global Top Chinese Patent Medicine for Bones and Muscles Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chinese Patent Medicine for Bones and Muscles as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Chinese Patent Medicine for Bones and Muscles Revenue in 2024

Figure 19. North America Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Chinese Patent Medicine for Bones and Muscles Market Share by Country (2020-2031)

Figure 21. United States Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Chinese Patent Medicine for Bones and Muscles Market Share by Country (2020-2031)

Figure 25. Germany Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Share by Region (2020-2031)

Figure 33. China Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Chinese Patent Medicine for Bones and Muscles Market Share by Country (2020-2031)

Figure 41. Mexico Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Share by Country (2020-2031)

Figure 45. Turkey Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Zhongheng Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 49. Fangsheng Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 50. Yunnan Baiyao Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 51. Beijing TRT Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 52. Pien Tze Huang Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 53. BaiYunShan Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 54. China Resources Sanjiu Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 55. Yiling Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 56. Jumpcan Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 57. Tasly Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 58. Buchang Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 59. Sunflower Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 60. Ginwa Enterprise Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 61. KPC Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 62. Jiangsu Kanion Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 63. Xintian Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 64. Henan Lingrui Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions